Anesthetic considerations in myofibrillar myopathy

Area of Science:

• Genetics
• Neurology
• Cardiology

Background:

• Myofibrillar myopathy (MFM) is a progressive genetic muscle disorder affecting cardiac, skeletal, and smooth muscles.
• MFM presents with diverse phenotypes, increasing risks of respiratory failure, cardiac abnormalities, cardiomyopathy, and sudden cardiac death.
• Severe skeletal muscle involvement can lead to contractures, respiratory insufficiency, and airway compromise.

Observation:

• This study reports the anesthetic management of a child with genetically confirmed BAG3-myopathy, a severe childhood-onset MFM subtype.
• Multiple anesthetic encounters were managed, providing valuable clinical experience.
• The case highlights the importance of understanding MFM's anesthetic implications.

Findings:

• The anesthetic management focused on potential risks associated with MFM.
• Specific considerations included susceptibility to malignant hyperthermia and rhabdomyolysis.
• Patient sensitivity to various anesthetic agents was explored.

Implications:

• This is the first report detailing anesthetic management for Myofibrillar Myopathy.
• Findings offer crucial guidance for anesthesiologists managing patients with BAG3-myopathy and similar MFM subtypes.
• Understanding these anesthetic implications is vital for improving patient outcomes and safety.